Independent Research Providers have gained a boost from evolving regulations to deliver accurate, unbiased, and up-to-date research about initial public offerings and the global markets.
Sign Up NowUpcoming IPOs
That was then
IPO monopoly
Research about companies listing in the public markets through initial public offerings (IPOs) has previously been monopolised by established players like investment banks. This used to put independent analysts and researchers at a disadvantage.
This is now
Level playing field
The evolution of regulatory frameworks around the world has opened the door for independent experts to gain access to companies that plan to go public, before analysts in banks that are working on those IPOs.
The benefits
No conflict
Independent analysts who are not directly involved in the IPOs provide unbiased, balanced research and analysis that is more valuable to investors.
Diversity
More experts having access to company management results in a broader spectrum of ideas and more sophisticated independent analysis.
Transparency
IPO research produced by banks involved in the IPOs can be influenced by the working relationship between the bank and company.
Depth
Independent Research Providers can specialise and find their niche in specific markets to produce differentiated, in-depth IPO research.
The power of the network
IPO Research on Smartkarma
Independent Research Providers on Smartkarma are producing unbiased, actionable Insights on IPOs such as Meituan-Dianping, Sonos, ICICI Securities, Mercari, and China Tower. Tools like IPO Analyser provide insights on deal terms, corporate governance, index and peers momentum, and more.